The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis
Open Access
- 1 January 2005
- journal article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 37 (6), 319-324
- https://doi.org/10.4143/crt.2005.37.6.319
Abstract
Cervical cancer is one of the leading world causes of cancer morbidity and mortality in woman, with more than 98% related to a human papillomavirus (HPV) infection origin. Infection with specific subtypes of HPV has been strongly implicated in cervical carcinogenesis. The identification and functional verification of host proteins associated with HPV E6 and E7 oncoproteins may provide useful information in understanding cervical carcinogenesis and the development of cervical cancer-specific markers. The advent of functional genomics and proteomics has provided hope of discovering novel biological markers for use in the screening, early diagnosis, prognostication and prediction of response to therapy. Herein, we review the studies where the profiles of host proteins associated with HPV E6 and E7 oncoproteins in cervical cancer were generated.Keywords
This publication has 27 references indexed in Scilit:
- Protein profiling and identification of modulators regulated by the E7 oncogene in the C33A cell line by proteomics and genomicsProteomics, 2004
- A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycleOncogene, 2002
- BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial ApoptosisMolecular Cell, 2001
- Livin, a Novel Inhibitor of Apoptosis Protein Family MemberOnline Journal of Public Health Informatics, 2001
- Interaction of human Ku70 with TRF2FEBS Letters, 2000
- Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancersCancer Letters, 2000
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- The Human Papillomavirus E7 Oncoprotein Abrogates Signaling Mediated by Interferon-αVirology, 1999
- Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activationCell, 1991